Literature DB >> 22956771

Extracellular quaternary ammonium blockade of transient receptor potential vanilloid subtype 1 channels expressed in Xenopus laevis oocytes.

Ricardo E Rivera-Acevedo1, Stephan A Pless, Stephan K W Schwarz, Christopher A Ahern.   

Abstract

Transient receptor potential vanilloid subtype 1 (TRPV1) channels are essential nociceptive integrators in primary afferent neurons. These nonselective cation channels are inhibited by local anesthetic compounds through an undefined mechanism. Here, we show that lidocaine inhibits TRPV1 channels expressed in Xenopus laevis oocytes, whereas the neutral local anesthetic, benzocaine, does not, suggesting that a titratable amine is required for high-affinity inhibition. Consistent with this possibility, extracellular tetraethylammonium (TEA) and tetramethylammonium application produces potent, voltage-dependent pore block. Alanine substitutions at Phe649 and Glu648, residues in the putative TRPV1 pore region, significantly abrogated the concentration-dependent TEA inhibition. The results suggest that large cations, shown previously to enter cells through activated transient receptor potential channels, can also act as channel blockers.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22956771     DOI: 10.1124/mol.112.079277

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  4 in total

1.  Analgesic transient receptor potential vanilloid-1-active compounds inhibit native and recombinant T-type calcium channels.

Authors:  Jeffrey R McArthur; Rocio K Finol-Urdaneta; David J Adams
Journal:  Br J Pharmacol       Date:  2019-05-16       Impact factor: 8.739

2.  Expression-dependent pharmacology of transient receptor potential vanilloid subtype 1 channels in Xenopus laevis oocytes.

Authors:  Ricardo E Rivera-Acevedo; Stephan A Pless; Stephan K W Schwarz; Christopher A Ahern
Journal:  Channels (Austin)       Date:  2013-01-01       Impact factor: 2.581

3.  Permeation and block of TRPV1 channels by the cationic lidocaine derivative QX-314.

Authors:  Michelino Puopolo; Alexander M Binshtok; Gui-Lan Yao; Seog Bae Oh; Clifford J Woolf; Bruce P Bean
Journal:  J Neurophysiol       Date:  2013-01-09       Impact factor: 2.714

4.  TRPV Channels in Mast Cells as a Target for Low-Level-Laser Therapy.

Authors:  Lina Wang; Di Zhang; Wolfgang Schwarz
Journal:  Cells       Date:  2014-06-26       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.